Arch Biopartners Hires Investor Relations Firm
(firmenpresse) - TORONTO, ONTARIO -- (Marketwire) -- 07/18/11 -- Arch Biopartners Inc ("Arch" or the "Company")(CNSX: ACH)(OTC: FOIFF) announced today it has retained the services of Renmark Financial Communications Inc. (Renmark") to perform investor relations activities.
In consideration of the services to be provided, the Company has agreed to a one year contract starting August 1st, 2011 and will pay Renmark a monthly fee starting at $4000 per month. The contract can be terminated by either party with 30 days notice. Renmark does not have any interest, directly or indirectly, in Arch Biopartners Inc. or its securities, or any right or intent to acquire such an interest.
About Arch Biopartners
Arch Biopartners is a portfolio based biotechnology company established to develop new products and technology for sale to pharmaceutical and industrial companies.
For more information on the Company, please consult the other public documents filed on SEDAR at .
The Company's website address is: .
Forward-Looking Statements
All statements, other than statements of historical fact, in this news release are forward looking statements that involve various risks and uncertainties, including, without limitation, statements regarding the future plans and objectives of the Company. There can be no assurance that such statements will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. The Company assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.
The CNSX has not reviewed and does not accept responsibility for the adequacy of this release.
Contacts:
Arch Biopartners Inc.
Richard Muruve
CEO
(647) 428 7031
Renmark Financial Communications Inc.
Christine Stewart
(514) 939-3989 or (416) 644-2020
Renmark Financial Communications Inc.
Matthew Planche
(514) 939-3989 or (416) 644-2020
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 18.07.2011 - 12:55 Uhr
Sprache: Deutsch
News-ID 35361
Anzahl Zeichen: 0
contact information:
Town:
TORONTO, ONTARIO
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 230 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Arch Biopartners Hires Investor Relations Firm"
steht unter der journalistisch-redaktionellen Verantwortung von
Arch Biopartners Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
